News/ News/ Sales and Marketing Jazz agrees $7.2bn deal to buy cannabis meds pathfinder GW Pharma Phil Taylor cannabis, Epidiolex, GW Pharma, Jazz Pharmaceuticals, M&A 0 Comment Jazz Pharma has agreed a $7.2 billion deal to by GW Pharmaceuticals and its pioneering cannabis-derived medicines, headed Share X Jazz agrees $7.2bn deal to buy cannabis meds pathfinder GW Pharma https://pharmaphorum.com/news/jazz-agrees-7-2bn-deal-to-buy-cannabis-meds-pathfinder-gw-pharma/
cannabis, Epidiolex, GW Pharma, Jazz Pharmaceuticals, M&A
0 Comment
